Among both civilian and veteran populations, substance use disorders (SUDs) and anxiety
disorders frequently co-occur. One of the most common comorbid anxiety disorder is …

Thirty years of research on the biology of posttraumatic stress disorder now provides a
foundation for hypotheses related to the mechanisms underlying the pharmacotherapy of …

Post-traumatic stress disorder (PTSD) is often a chronic and disabling anxiety disorder that
develops after exposure to a traumatic event. Researchers have demonstrated efficacy for …

Many veterans returning from service in Afghanistan or Iraq suffer from post-traumatic stress
disorder or mild traumatic brain injury. Treating these conditions can be challenging …

Post-traumatic stress disorder (PTSD) can result from a traumatic experience that elicits
emotions of fear, helpless or horror. Most individuals remain asymptomatic or symptoms …

Objective: Growing awareness of the psychological effects of trauma has emphasized the
need for clinicians across a range of practice settings to be aware of evidence-based …

Objective: To determine the efficacy, safety, and tolerability of vilazodone in the treatment of
posttraumatic stress disorder (PTSD) with comorbid mild-to-moderate depression. Methods …

Background Post-traumatic stress disorder (PTSD) has become an important public health
problem. However, the conventional therapeutic strategy, including pharmacotherapy and …

The study of early intervention following exposure to traumatic stress has accelerated greatly
in the past decade, with the goal of finding ways to prevent the psychopathology and …